Wikipedia - DihydrotestosteroneFor other uses, see DHT (disambiguation).
Dihydrotestosterone (DHT) Full name: 5a-Dihydrotestosterone, abbreviating to 5a-DHT; INN: androstanolone is a biologically active metabolite of the hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, and adrenal glands by the enzyme 5a-reductase by means of reducing the 4,5 double-bond. Dihydrotestosterone belongs to the class of compounds called androgens, also commonly called androgenic hormones or testoids. Androgens are part of the biology of gender by stimulating and controlling the development and maintenance of masculine characteristics.
[edit] Significance
Testosterone. Note the major difference -- the 4,5 double-bond on the A (leftmost) ring.
DHT is a hormone produced in different amounts by both males and females, and is responsible for the formation of sex-specific characteristics in men. DHT has 3 times greater affinity for androgen receptors than testosterone and has 15-30 times greater affifinty than adrenal androgens. DHT plays an important role in the development of male secondary sex characteristics.[1] An illustration of the significance of DHT for the development of secondary sex characteristics is congenital 5-a-reductase (5-AR)deficiency which can result in pseudohermaphroditism, undeveloped male genitalia and prostate. These individuals are often raised as girls due to their lack of consipicuous male genitalia. When puberty occurs, although their DHT levels remain very low, their testosterone levels elevate normally. Their musculature develops like that of other adults, confirming that testosterone is the prominent contributor in the development of muscle mass. They end up with little or no pubic and body hair and no incidence of male pattern baldness (MPB).[2] Unlike other androgens such as testosterone, DHT cannot be converted by the enzyme aromatase to estradiol. Therefore, it is frequently used in research settings to distinguish between effects of testosterone caused by binding to the androgen receptor and those caused by testosterone's conversion to estradiol and subsequent binding to estrogen receptors.[3] [edit] PathologyDHT is the primary contributing factor in male pattern baldness (MPB).[4][5] Female hair loss is more complex, and DHT is only one of several possible causes.[6] Women with increased levels of DHT may develop certain androgynous male secondary sex characteristics, including a deepened voice and facial hair. DHT plays a role in the development and exacerbation of benign prostatic hyperplasia (BPH), as well as prostate cancer, by enlarging the prostate gland.[7] Prostate growth and differentiation are highly dependent on sex steroid hormones, particularly DHT.[8] [edit] TreatmentThe drugs belonging to the group known as 5a-reductase inhibitors are finasteride and dutasteride. Dutasteride is approved for the treatment of BPH and is prescibed off-label for the treatment of MPB, whereas finasteride is approved for both conditions. Dutasteride is three times more potent than finasteride in inhibiting the Type II enzyme and 100 times more potent than finasteride in inhibiting the Type I form of the DHT-producing enzyme, which finasteride does not inhibit. Both Type I and Type II are found in the hair follicle, though a recent study has shown that Type I is also present in the human brain, but the function remains unclear.[9] Currently, DHT hormone replacement therapy does not exist as a treatment for DHT androgen deficiency. [edit] See also[edit] References
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Dihydrotestosterone". |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




